Notice to health care providers : Updated guidelines for evaluation of severe respiratory illness associated with Middle East Respiratory Syndrome coronavirus (MERS-CoV)

Details

• Corporate Authors:
  Centers for Disease Control and Prevention (U.S.)
• Description:
  June 7, 2013, 8:00 p.m. ET
  
  CDCHAN-00348
  
  Summary: The Centers for Disease Control and Prevention (CDC) is working closely with the World Health Organization (WHO) and other partners to better understand the public health risk posed by Middle East Respiratory Syndrome Coronavirus (MERS-CoV), a novel coronavirus that was first reported to cause human infection in September 2012. No cases have been reported in the United States. The purpose of this HAN Advisory is to provide updated guidance to state health departments and health care providers in the evaluation of patients for M ER S-C oV infection including expansion of availability of laboratory testing and, in consultation with WHO, expansion of the travel history criteria for patients under investigation from within 10 to 14 days for investigation and modification of the case definition. Please disseminate this information to infectious diseases specialists, intensive care physicians, internists, infection preventionists, as well as to emergency departments and microbiology laboratories.
  
  
• Subjects:
  Communicable Disease Control Middle East Respiratory Syndrome Coronavirus Respiratory Tract Infections Severe Acute Respiratory Syndrome
• Source:
  HAN ; 348
• Series:
  Health Alert Network
• Document Type:
  HAN Health Update
• Place as Subject:
  Indiana
• Pages in Document:
  4 unnumbered pages
• Issue:
  348
• Collection(s):
  Health Alert Network (HAN)
• Main Document Checksum:
  urn:sha-512:4f1403c6c1a51f2428476b00dbe91362993e7bf27b42f558e8ce1f92e3021c1b4281bea2fefd58ce37a333f8043f27b7fa91cadb0649e63435ba092231155810
• Download URL:
  https://stacks.cdc.gov/view/cdc/25257/cdc_25257_DS1.pdf
• File Type:
  [PDF - 2.46 MB ]